G-switch¢â Activators and Inhibitors
|
|
|
|
|
Rho family proteins°ú pathwaysÀÇ Å¸°ÙÀ» ¼±ÅÃÀûÀ¸·Î ÀÛ¿ëÇÏ´Â Activators¿Í Inhibitors¸¦ ¼Ò°³ÇÕ´Ï´Ù. |
|
| Cytoskeleton |
- endogenous Rho family membersÀÇ °·ÂÇÑ(5~10¹è) activatorÀÔ´Ï´Ù.
- Ÿ°Ù ´Ü¹éÁúÀÇ over-expressionÀ̳ª knockdown¿¡ ÀÇÁ¸ÇÏ´Â ±âÁ¸ ¹æ¹ý°ú´Â ´Þ¸® G-switch¢âÀÇ ½Ã¾àÀº ¹ÝÀÀÀ» »ý¼ºÇÏ´Â ±âȸ¸¦ ÃÖÀûȽÃÄÑÁÖ°í, 2-4½Ã°£ ¾È¿¡ activationµË´Ï´Ù.
- multiple cell type¿¡µµ È¿°úÀûÀÔ´Ï´Ù.
Dose-dependent activation of RhoA in Swiss 3T3 cells using CN03.
Actin cytoskeleton morphological changes induced by CN03 treatment of Swiss 3T3 cells. Swiss 3T3 fibroblasts plated on glass coverslips, grown for 2 days in DMEM plus 10% FBS, serum starved for 24 h in media containing 1% FBS followed by 24 h in serum free media. Cells were treated with a buffer control (A) or 1 u/ml CN03 for 2 h at 37¡ÆC/5% CO2. Cells were then fixed, stained with Acti-stain¢â 488 phalloidin (Cat.#PHDG1), and visualized by fluorescence microscopy. Images were taken at a magnification of 40x. The control cells (A) exhibited mainly edge ruffling, some lamellipodia and very few stress fibers, whereas treatment with CN03 (B) resulted in the development of abundant stress fibers with some edge ruffling. Under similar conditions, RhoA was activated ~10-fold as determined using the RhoA G-LISA¢ç activation assay (Cat.# BK124).